Regnante Keith

CHIEF FINANCIAL OFFICER at KROS; Chief Financial Officer at WVE

Sold, on record
$5.4M
Dollars the filings state
Form 4 sales
6
Latest Feb 18, 2026
Form 144 notices
3
Proposed sales
Companies
2
Filed as an executive or holder

Companies

  • KROSKeros Therapeutics, Inc.CHIEF FINANCIAL OFFICER
  • WVEWave Life Sciences, Inc.Chief Financial Officer

Sales by reason

0
Routine
0
Plan not stated
1
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale WVEUnusual
    Sep 24, 2018 2018

    Sold 29,500 shares at $55.00 ($1.6M)

    Regnante Keith, Chief Financial Officer

    Sold 63.5% of holdings ($2.6M position)16,984 shares leftFiling

  2. 2 Form 4 sale WVEPlan not stated
    Feb 19, 2019 +148 days

    Sold 1,298 shares at $36.84 ($48k)

    Regnante Keith, Chief Financial Officer

    Sold 7.6% of holdings ($626k position)15,686 shares leftFiling

  3. 3 Form 144 notice KROSNotice
    Jun 8, 2023 +1570 days

    Filed to sell 20,000 shares ($956k)

    Regnante Keith, Officer

    10b5-1 planFirst sale on recordFiling

  4. 4 Form 144 notice KROSNotice
    Jun 9, 2023 +1 day

    Filed to sell 20,000 shares ($908k)

    Regnante Keith, Officer

    10b5-1 planFirst sale on recordFiling

  5. 5 Form 4 sale KROSRoutine
    Jun 9, 2023 same day

    Sold 40,000 shares at $46.61 ($1.9M)

    Regnante Keith, Chief Financial Officer

    10b5-1 planSold 100% of holdings ($1.9M position)0 shares leftFirst sale on recordFollows a Form 144Filing

  6. 6 Form 4 sale KROSUnusual
    Nov 4, 2023 +148 days

    Sold 40,000 shares at $45.29 ($1.8M)

    Regnante Keith, Chief Financial Officer

    No 10b5-1 planSold 100% of holdings ($1.8M position)0 shares leftFiling

  7. 7 Form 144 notice KROSNotice
    Jan 4, 2024 +61 days

    Filed to sell 40,000 shares ($1.8M)

    Regnante Keith, Officer

    10b5-1 planFiling

  8. 8 Form 4 sale KROSNo plan
    Feb 18, 2026 +776 days

    Sold 4,739 shares at $16.35 ($77k)

    Regnante Keith, CHIEF FINANCIAL OFFICER

    No 10b5-1 planSold 10.8% of holdings ($719k position)39,261 shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (9)

Form 144 notices and Form 4 sales by Regnante Keith
Source
Feb 18, 2026Feb 20, 2026KROSCHIEF FINANCIAL OFFICERForm 4 sale4,739$77k10.8%No planSEC
Jan 4, 2024Jan 4, 2024KROSOfficerForm 144 notice40,000$1.8MNoticeSEC
Nov 4, 2023Jan 8, 2024KROSChief Financial OfficerForm 4 sale40,000$1.8M100.0%UnusualSEC
Jun 9, 2023Jun 12, 2023KROSChief Financial OfficerForm 4 sale40,000$1.9M100.0%RoutineSEC
Jun 9, 2023Jun 9, 2023KROSOfficerForm 144 notice20,000$908kNoticeSEC
Jun 8, 2023Jun 8, 2023KROSOfficerForm 144 notice20,000$956kNoticeSEC
Feb 19, 2019Feb 21, 2019WVEChief Financial OfficerForm 4 sale1,298$48k7.6%Plan not statedSEC
Sep 24, 2018Sep 26, 2018WVEChief Financial OfficerForm 4 sale29,500$1.6M63.5%UnusualSEC
Feb 16, 2018Feb 21, 2018WVEChief Financial OfficerForm 4 sale316$16k1.8%Plan not statedSEC